Le Lézard
Classified in: Health, Science and technology
Subject: CCA

Invitation to Presentation of Sectra's Six-month Interim Report on November 29, 2019


LINKÖPING, Sweden, Nov. 14, 2019 /PRNewswire/ -- The international medical imaging IT and cybersecurity company Sectra (STO: SECT B) will publish its interim report for the period May to October 2019 on November 29, 2019. Sectra invites analysts, investors, and the media to attend a teleconference/audiocast in conjunction with the publication of the report. 

Publication of the interim report: 8:15 a.m. (CET) November 29, 2019

Presentation and audiocast: 10:00 a.m. (CET) November 29, 2019

To participate, follow online at investor.sectra.com/q2report2019 or call one of the following numbers five to ten minutes before the conference begins:

SE: +46850558356
UK: +443333009261
US: +18338230586

Sectra management will present the interim report and answer any questions. The presentation will be held in English and a recorded version will be available via investor.sectra.com/q2report2019 after the conference.

Approximately 30 minutes before the start, a PDF version of the presentation will be available for download.

Sectra's financial report calendar     

Further information about Sectra's financial events and interim reports: investor.sectra.com/events-and-presentations/

Subscribe for information

To subscribe to financial reports, invitations, and information from Sectra via email, please fill in your contact information at investor.sectra.com/subscribe 

About Sectra 
Sectra assists hospitals throughout the world to enhance the efficiency of care, and authorities and defense forces in Europe to protect society's most sensitive information. Thereby, Sectra contributes to a healthier and safer society. The company was founded in 1978, has its head office in Linköping, Sweden, with direct sales in 19 countries, and operates through partners worldwide. Sales in the 2018/2019 fiscal year totaled SEK 1,413 million. The Sectra share (STO: SECT B) is quoted on the Nasdaq Stockholm exchange. For more information, visit https://sectra.com/.

For further information, please contact: 

Helena Pettersson, Chief Investor Relations Officer Sectra AB, ph 46-13-23-52-04, e-mail info.investor@sectra.com

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/sectra/r/invitation-to-presentation-of-sectra-s-six-month-interim-report-on-november-29--2019,c2961667

SOURCE Sectra


These press releases may also interest you

at 12:05
Stoke Therapeutics, Inc. , a biotechnology company pioneering a new way to treat the underlying cause of severe genetic diseases by precisely upregulating protein expression, today announced preclinical data from studies of STK-001 that showed...

at 12:05
Mallinckrodt plc , a global biopharmaceutical company, today announced findings on the use of a novel predictive model designed to more quickly identify infants with infantile spasms (IS), a rare seizure disorder that typically occurs between three...

at 11:05
Aptose Biosciences Inc. released highlights from a corporate event and clinical update today held at the 61st American Society of Hematology (ASH) Annual Meeting and Exposition in Orlando, FL. The event was hosted by the Aptose management team and...

at 10:25
The Janssen Pharmaceutical Companies of Johnson & Johnson announced today initial results from the Phase 1b/2 CARTITUDE-1 study (NCT03548207) evaluating the efficacy and safety of JNJ-68284528 (JNJ-4528), an investigational B cell maturation antigen...

at 10:20
The Janssen Pharmaceutical Companies of Johnson & Johnson today announced combination data from two studies and a long-term integrated analysis evaluating the use of Imbruvica® (ibrutinib) for the treatment of previously untreated patients with CLL....

at 10:10
Epizyme, Inc. , a late-stage biopharmaceutical company developing novel epigenetic therapies, today reported positive, mature data at the 2019 American Society of Hematology (ASH) Annual Meeting from its ongoing Phase 2 trial of tazemetostat, an oral...



News published on 14 november 2019 at 07:38 and distributed by: